1291eP Pola-R-CHP regimen as first-line treatment for newly diagnosed high-risk diffuse large B-cell lymphoma (DLBCL) patients.
Saved in:
| Title: | 1291eP Pola-R-CHP regimen as first-line treatment for newly diagnosed high-risk diffuse large B-cell lymphoma (DLBCL) patients. |
|---|---|
| Authors: | Pi, J.1 (AUTHOR), He, X.2 (AUTHOR), Zhou, S.2 (AUTHOR), Liu, P.2 (AUTHOR), Yang, J.2 (AUTHOR), Wei, G.1 (AUTHOR), Wang, T.1 (AUTHOR), Jin, J.1 (AUTHOR), Lin, Y.1 (AUTHOR), Lv, Q.1 (AUTHOR), Zhang, W.1 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS814-S815. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 189419725 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1291eP Pola-R-CHP regimen as first-line treatment for newly diagnosed high-risk diffuse large B-cell lymphoma (DLBCL) patients. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Pi%2C+J%2E%22">Pi, J.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22He%2C+X%2E%22">He, X.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+S%2E%22">Zhou, S.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+P%2E%22">Liu, P.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+J%2E%22">Yang, J.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wei%2C+G%2E%22">Wei, G.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+T%2E%22">Wang, T.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jin%2C+J%2E%22">Jin, J.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lin%2C+Y%2E%22">Lin, Y.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lv%2C+Q%2E%22">Lv, Q.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+W%2E%22">Zhang, W.</searchLink><relatesTo>1</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS814-S815. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189419725 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2025.08.1925 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S814 Titles: – TitleFull: 1291eP Pola-R-CHP regimen as first-line treatment for newly diagnosed high-risk diffuse large B-cell lymphoma (DLBCL) patients. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pi, J. – PersonEntity: Name: NameFull: He, X. – PersonEntity: Name: NameFull: Zhou, S. – PersonEntity: Name: NameFull: Liu, P. – PersonEntity: Name: NameFull: Yang, J. – PersonEntity: Name: NameFull: Wei, G. – PersonEntity: Name: NameFull: Wang, T. – PersonEntity: Name: NameFull: Jin, J. – PersonEntity: Name: NameFull: Lin, Y. – PersonEntity: Name: NameFull: Lv, Q. – PersonEntity: Name: NameFull: Zhang, W. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2025 Supplement 2 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 36 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |